Characterization of tirzepatide‐treated patients achieving different glycemic control levels in SURPASS‐AP‐Combo
Obesity · 2024
DOI: 10.1002/oby.24030 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Obesity, 2024. Verfasst von Yuqian Bao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycated Hemoglobin, Glycemic Control, Blood Glucose. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Objective
The study objective was to characterize subgroups of Asia‐Pacific patients with type 2 diabetes who achieved different glycated hemoglobin (HbA1c) targets on tirzepatide treatment.
Methods
This was a post hoc analysis of the SURPASS AP‐Combo study. Baseline characteristics, changes in metabolic markers, and safety were compared between tirzepatide‐treated patients achieving HbA1c
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Eli Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
- Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
ORCID-Profile: Linong Ji
Förderung
- Eli Lilly and Company
Zitieren
APA
Bao, Y., Han, L., Du, L., & Ji, L. (2024). Characterization of tirzepatide‐treated patients achieving different glycemic control levels in SURPASS‐AP‐Combo. Obesity. https://doi.org/10.1002/oby.24030
Vancouver
Bao Y, Han L, Du L, Ji L. Characterization of tirzepatide‐treated patients achieving different glycemic control levels in SURPASS‐AP‐Combo. Obesity. 2024. doi:10.1002/oby.24030
BibTeX
@article{Bao2024,
author = {Bao, Yuqian and Han, Lin and Du, Liying and Ji, Linong},
title = {Characterization of tirzepatide‐treated patients achieving different glycemic control levels in SURPASS‐AP‐Combo},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.24030}
}
EUVIMED